New Batches

Brand new clinical-grade molecules or additional batches of existing ones, added recently to the in-stock potfolio

Filter our product list:

API

Abatacept

Adalimumab

Adalimumab biosimilar

ADCs

Aflibercept

Albutrepenonacog alfa

Aldesleukin

Alemtuzumab

Alglucosidase alfa

Alteplase

Amivantamab

Atezolizumab

Avalglucosidase alfa

Avelumab

Belatacept

Bevacizumab

Bevacizumab biosimilar

Biosimilar

Bispecifics

Blinatumomab

Brentuximab vedotin

Brodalumab

Canakinumab

Certolizumab pegol

Cetuximab

Daratumumab

Denosumab

Dornase alfa

Dostarlimab

Dulaglutide

Dupilumab

Durvalumab

Eculizumab

Efgartigimod alfa

Elotuzumab

Emicizumab

Enfortumab vedotin

Epoetin zeta

Eptinezumab

Etanercept

Etanercept biosimilar

Evinacumab

Evolocumab

Fusion protein

Galsulfase

Gemtuzumab ozogamicin

Glofitamab

Golimumab

Guselkumab

Inebilizumab

Infliximab

Infliximab biosimilar

Ipilimumab

Ixekizumab

Loncastuximab tesirine

Luspatercept

Mepolizumab

Mirikizumab

Mirvetuximab soravtansine

Mogamulizumab

Mosunetuzumab

Natalizumab

Nirsevimab

Nivolumab

Obinutuzumab

Ocrelizumab

Octocog alfa

Omalizumab

Paclitaxel

Palivizumab

Panitumumab

Pembrolizumab

Pertuzumab

Polatuzumab vedotin

Ramucirumab

Ranibizumab

Ranibizumab biosimilar

Ravulizumab

Risankizumab

Rituximab

Rituximab biosimilar

Romiplostim

Sacituzumab govitecan

Secukinumab

Siltuximab

Tebentafusp

Teclistamab

Tisotumab vedotin

Tixagevimab and Cilgavimab

Tocilizumab

Trastuzumab

Trastuzumab biosimilar

Trastuzumab deruxtecan

Trastuzumab emtansine

Ustekinumab

Vedolizumab

Velaglucerase alfa

Antigen / Target

alpha 4 beta 7 integrin

alpha-4 integrin

ANGPTL3

B cell maturation antigen

BAFF

BCMA

C. difficile toxin B

C5 complement protein

CCR4

CD19

CD20

CD22

CD3

CD30

CD33

CD38

CD52

CD79b

CD80

CD86

CGRP

CGRP ligand

Clotting Factor IX

Clotting Factor IXa and X

Clotting Factor VIII

CP (classical pathway)

CTLA-4

Dermatan sulfate

DNA in cystic fibrosis mucus

EGFR

EPO receptor

Fc Receptor (FcRn)

FGF23

FRɑ

GLP-1

Glucosylceramidase

HER2

IFNAR1

IgE

IL-1 beta

IL-12

IL-13

IL-17A

IL-17A/F

IL-17AF

IL-17F

IL-17RA

IL-23

IL-2RB

IL-36R

IL-4

IL-5

IL-5 receptor alpha

IL-6

IL-6 receptor

IL13

Lysosomal glycogen

MET

Nect

P-selectin

PCSK9

PD-1

PD-L1

Perilipin-3

PIGF

plasma kallikrein

Plasminogen activator (rt-PA)

PlGF

PTH1

RANKL

Respiratory syncytial virus (RSV)

RSV protein F

SARS-CoV-2 Spike

sclerostin

SLAMF7

TCR targeting domain

TGF-beta

Tissue factor (TF)

TNF alpha

TNFSF13B

TPO receptor (cMpl)

Trop-2-directed ADC

TSLP

Tubulin

VEGF

VEGF-A

VEGF-B

VEGFR2

α- and β- CGPR

Therapeutic Areas

Acute heart disease

Ankylosing Spondylitis

Antiviral

Auto-immune diseases

Autosomal recessive disorder

Blood diseases

Bone diseases

Cardio vascular disease

Crohn's Disease

Dermatology

Enzyme replacement

Gene therapy

Hematology

Hypercholesterolemia

Idiopathic

Immune disorder

Immuno-oncology

Immunotherapy

Infectious diseases

Inflammation

Juvenile rheumatoid arthritis

Lupus

Migraine disorders

Neurological Diseases

Obstructive airway diseases

Oncology

Ophthalmology

Orthopedics

plaque psoriasis

Psoriasis

Psoriatic Arthritis

Pulmonology

Purpura

Respiratory Disease

Thrombocytopenic

Ulcerative colitis

Urology

Uveitis

Therapeutic Indications

Active autoantibody-positive systemic lupus erythematosus (SLE)

Active rheumatoid arthritis

Acute lymphoblastic leukemia

Acute myeloid leukaemia (AML)

Adult Crohn's Disease

Advanced endometrial cancer (EC)

Age-related macular degeneration

Allergic asthma

Ankylosing Spondylitis

atherosclerotic cardiovascular disease

Atopic dermatitis

Atypical haemolytic uremic syndrome (aHUS)

Axial spondyloarthritis

B-cell lymphoma

Basal Cell Carcinoma

Bone Resorption

Breast cancer

Breast Neoplasm

Brest cancer

Cervical cancer

Chronic lymphocytic leukaemia and Rheumatoid arthritis

Chronic lymphocytic leukemia

Chronic primary immune thrombocytopenia

Chronic renal failure

Clostridium difficile infection (CDI)

Colorectal cancer

Colorectal Neoplasms

COVID-19

Crohn's Disease

Cryopyrin-associated periodic syndromes

Cutaneous Squamous Cell Carcinoma

Cystic fibrosis

Diabetic macular oedema (DMO)

Diabetic Retinopathy

Diffuse large B-cell lymphoma (DLBCL)

Early breast cancer

Eosinophilic asthma

Esophageal cancer

Extensive-stage small cell lung cancer

Falopian tube cancer

Flares in adult patients with generalised pustular psoriasis

Follicular B-cell non-Hodgkin's lymphoma (NHL)

Follicular lymphoma (FL)

Gastric cancer

Gaucher disease

Generalised myasthenia gravis (gMG)

Gouty arthritis

Granulomatosis with polyangiitis and microscopic polyangiitis

Haemolytic anaemia

Haemophilia A

Haemophilia B

Hepatocellular cancer

Hepatocellular carcinoma

Hereditary angioedema

Hidradenitis Suppurativa

High-grade B-cell lymphoma (HGBL)

Hodgkin Disease

Homozygous familial hypercholesterolaemia

Hypercholesterolaemia and mixed dyslipidaemia

Juvenile idiopathic arthritis

Juvenile rheumatoid arthritis

Kaposi's sarcoma

low-density lipoprotein-cholesterol (LDL-C)

Lung cancer

Macular Edema

Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO)

Melanoma

Merkel cell carcinoma

Metastatic breast cancer

Metastatic colorectal cancer (mCRC)

Metastatic renal cell carcinoma

Metastatic urothelial cancer

Mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) recurrent

Mucopolysaccharidosis VI

Multicentric Castleman’s disease

Multiple Myeloma

Multiple Sclerosis

Multiple sclerosis (RMS)

Myasthenia Gravis (gMG)

Mycosis fungoides (MF) or Sézary syndrome (SS)

Myopic choroidal neovascularisation (myopic CNV)

Neovascular (wet) age-related macular degeneration (AMD)

Neuromyelitis optica spectrum disorder (NMOSD)

Neuromyelitis optica spectrum disorders (NMOSD)

Non-Hodgkin's lymphoma

Non-Small Cell Lung Cancer

Non-Small-Cell Lung Carcinoma (NSCLC)

Other inherited metabolic or neuromuscular diseases

Ovarian cancer

Ovarian Neoplasms

paedi

Paediatric Crohn's Disease

Paediatric plaque psoriasis

Paediatric Ulcerative colitis

Paediatric Uveitis

Pancreatic cancer

Paroxysmal nocturnal haemoglobinuria

Pemphigus vulgaris

Periodic fever syndromes

Plaque psoriasis

Polyarticular juvenile idiopathic arthritis

Pompe disease

Postmenopausal Osteoporosis

Primary Immune Thrombocytopenia (ITP)

Primary peritoneal cancer

Prophylaxis of graft rejection

Prophylaxis of migraine

Prophylaxis of migraine in adults

Psoriasis

Psoriatic Arthritis

Radiation to bone

Refractory generalized myasthenia gravis

Relapsed or refractory follicular lymphoma (FL)

Renal Cell Carcinoma (RCC)

Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus Infection

Retinal vein occlusion (RVO)

Rheumatoid Arthritis

Severe asthma

Severe eosinophilic asthma

Severe osteoporosis

Skeletal related events

Small cell lung cancer

Spinal cord compression or surgery to bone

Spondylarthropathies

Squamous Cell Carcinoma of Head and Neck

Still’s disease

Stomach Neoplasms

Systemic lupus erythematosus

Thrombolytic treatment in acute myocardial infarction

Transfusion-dependent anaemia

Transitional Cell Carcinoma

Type 2 diabetes

Ulcerative colitis

Unresectable or metastatic HER2-positive breast cancer

Unresectable or metastatic triple-negative breast cancer (mTNBC)

Unresectable or metastatic uveal melanoma

Urologic Neoplasms

Urothelial carcinoma

Uveitis

Vaso-occlusive crisis

Wild-type RAS metastatic colorectal cancer

X-linked hypophosphataemia

Classes of molecules

Antibody Fab'fragment

Antibody-drug conjugate (ADC)

Biosimilar

Bispecific Antibody

Bispecific fusion protein

Enzyme

Fusion protein

Glycoprotein

Glycoprotein hormone

Hormone

Monoclonal Antibody

Monoclonal Antibody-Fc engineered

Nanoparticle

Peptibody

Recombinant protein

Therapeutic peptides

Isotypes

ALDH1A1

Antibody Fab' fragment

Antibody fragment

Chimeric (human-murine) G1 Kappa

CTLA-4

Fc engineered

Fc portion of human IgG1

Fusion Protein (IgG1)

Fusion Protein (VEGF)

Glycoprotein

Humanised IgG2Δa/kappa

IgG - Chimeric (mouse/human)

IgG - Human

IgG - Humanized

IgG kappa - Fully human

IgG1

IgG1 - Chimeric

IgG1 - Chimeric (mouse/human)

IgG1 - Chimeric human-murine

IgG1 - Fc domain

IgG1 - Fully human

IgG1 - Human

IgG1 - Humanized

IgG1 kappa - Fully human

IgG1 Kappa - Humanized

IgG1 kappa-light chain

IgG1 lambda

IgG1 lambda - Fully human

IgG1 subtype

IgG1-Fc-domain

IgG1/kappa

IgG2

IgG2 - Fully human

IgG2 kappa

IgG2/4k

IgG2λ

IgG4

IgG4 - Fully human

IgG4 - Humanized

IgG4 kappa- Humanized

IgG4-PAA

Monoclonal antitoxin antibody

Monoclonal single chain Fv (scFv) antibody fragment

Recombinant DNA

Recombinant DNA-derived monoclonal antibody

Recombinant fusion protein

T-cell engager

T-cell receptor

Expiry Date

2024 2025 2026 2027

CoA

Filters Sort results

Reset Apply

No results found. Clear filters and try again?

Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products

aliquoted from medicines

Drug Aliquots

In Stock

Immediately available
From 1 vial per order

Download | In-stock aliquots

Drug Aliquots

On Demand

2-4 weeks lead time
Minimum order applies

Download | On-demand aliquots

Your Desired

Molecule

Which molecule(s)
are you looking for?